Display options
Share it on

ESC Heart Fail. 2017 Feb;4(1):40-45. doi: 10.1002/ehf2.12112. Epub 2016 Sep 20.

Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta-analysis.

ESC heart failure

Jufen Zhang, Riet Dierckx, Kevin Mohee, Andrew L Clark, John G Cleland

Affiliations

  1. Academic Cardiology, Castle Hill Hospital, Hull York Medical School, University of Hull Kingston upon Hull UK.
  2. Department of Cardiology, Cardiovascular Center, OLV Hospital Aalst Belgium.
  3. The National Heart and Lung Institute, Royal Brompton and Harefield Hospitals, Imperial College London UK.

PMID: 28217311 PMCID: PMC5292634 DOI: 10.1002/ehf2.12112

Abstract

BACKGROUND: Previous studies have shown that xanthine oxidase inhibitors (XOI) might improve outcome for patients with cardiovascular disease. However, more evidence is required.

METHODS AND RESULTS: We published a meta-analysis of trials conducted before 2014 examining the effects of XOI on mortality in patients with cardiovascular disease. At least two further trials (

CONCLUSIONS: This updated meta-analysis does not suggest that XOI exert a large reduction in mortality but also cannot exclude the possibility of substantial harm or benefit.

Keywords: Cardiovascular disease; Meta‐analysis; Mortality; Systematic review; Xanthine oxidase inhibition

References

  1. Recent Adv Stud Cardiac Struct Metab. 1976 May 26-29;11:555-8 - PubMed
  2. Heart. 2005 Jun;91(6):749-53 - PubMed
  3. Med Princ Pract. 2014;23(2):134-9 - PubMed
  4. Eur J Heart Fail. 2005 Jun;7(4):461-7 - PubMed
  5. ESC Heart Fail. 2017 Feb;4(1):40-45 - PubMed
  6. Eur Heart J. 2011 Mar;32(6):712-20 - PubMed
  7. Heart Lung Circ. 2015 Jul;24(7):660-6 - PubMed
  8. Ann Intern Med. 1999 Jul 6;131(1):7-13 - PubMed
  9. Kidney Int. 2005 May;67(5):1739-42 - PubMed
  10. J Thorac Cardiovasc Surg. 1994 Jan;107(1):248-56 - PubMed
  11. Am Heart J. 1991 Jan;121(1 Pt 1):20-4 - PubMed
  12. Cardiovasc Ther. 2014 Apr;32(2):57-8 - PubMed
  13. Circulation. 2001 Nov 13;104(20):2407-11 - PubMed
  14. J Hypertens. 2008 Feb;26(2):269-75 - PubMed
  15. J Clin Epidemiol. 1997 Sep;50(9):997-1002 - PubMed
  16. N Engl J Med. 2008 Oct 23;359(17):1811-21 - PubMed
  17. Eur J Heart Fail. 2015 Nov;17(11):1144-51 - PubMed
  18. Int J Cardiol. 2010 Jul 23;142(3):279-87 - PubMed
  19. Heart. 2002 Mar;87(3):229-34 - PubMed
  20. Int J Clin Pract. 2009 Sep;63(9):1327-33 - PubMed
  21. Open Med. 2009;3(3):e123-30 - PubMed
  22. Clin J Am Soc Nephrol. 2010 Aug;5(8):1388-93 - PubMed
  23. Cardiovasc Ther. 2012 Aug;30(4):217-26 - PubMed
  24. J Mol Cell Cardiol. 2005 Sep;39(3):531-6 - PubMed
  25. Ann Rheum Dis. 2016 Sep;75(9):1674-9 - PubMed
  26. J Geriatr Cardiol. 2015 Sep;12(5):515-20 - PubMed
  27. Circulation. 2003 Apr 22;107(15):1991-7 - PubMed
  28. Arch Biochem Biophys. 1999 Dec 15;372(2):285-94 - PubMed
  29. Circulation. 2015 May 19;131(20):1763-71 - PubMed
  30. Circ Res. 2006 Feb 3;98(2):271-9 - PubMed
  31. BMJ. 1997 Sep 13;315(7109):629-34 - PubMed
  32. Circ Res. 2000 Nov 10;87(10):840-4 - PubMed
  33. Eur J Cardiothorac Surg. 2010 Jul;38(1):86-90 - PubMed
  34. Pharmacol Rev. 2006 Mar;58(1):87-114 - PubMed
  35. Circ Res. 2002 Feb 22;90(3):297-304 - PubMed
  36. Circulation. 2004 Oct 12;110(15):2175-9 - PubMed
  37. Circ Res. 1999 Sep 3;85(5):437-45 - PubMed
  38. J Am Coll Cardiol. 2008 Jun 17;51(24):2301-9 - PubMed
  39. Heart. 1997 Jul;78(1):39-43 - PubMed
  40. Circulation. 2001 Feb 6;103(5):750-5 - PubMed
  41. Int J Cardiol. 2010 Nov 19;145(2):257-258 - PubMed
  42. Am J Physiol Heart Circ Physiol. 2006 Feb;290(2):H837-43 - PubMed

Publication Types